Use of CRTAM expression as a predictive biomarker for immune checkpoint blockade in a pan-cancer cohort

被引：0
|
作者：
Miyashita, Hirotaka
Nishizaki, Daisuke
Lee, Suzanna
Nesline, Mary K.
Conroy, Jeffrey M.
DePietro, Paul
Pabla, Sarabjot
Aoshima, Ken
Kato, Shumei
Kurzrock, Razelle
机构：
[1] Dartmouth Canc Ctr, Lebanon, NH USA
[2] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA
[3] Univ Calif San Diego, La Jolla, CA USA
[4] Labcorp Oncol, Buffalo, NY USA
[5] OmniSeq Inc, Labcorp, Buffalo, NY USA
[6] Univ Tsukuba, Sch Integrat & Global Majors, Tsukuba, Ibaraki, Japan
[7] Med Coll Wisconsin, Milwaukee, WI USA
[8] WIN Consortium, Milwaukee, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2630
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy
    Yang, Jing
    Zhao, Shilin
    Wang, Jing
    Sheng, Quanhu
    Liu, Qi
    Shyr, Yu
    CANCER RESEARCH, 2022, 82 (04) : 539 - 542
  • [2] MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
    Zhou, Yong
    Tan, Yuan
    Zhang, Qin
    Duan, Qianqian
    Chen, Jun
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [3] MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
    Yong Zhou
    Yuan Tan
    Qin Zhang
    Qianqian Duan
    Jun Chen
    European Journal of Medical Research, 27
  • [4] KDR mutation as novel biomarker for immune checkpoint inhibitors in pan-cancer
    Guo, Renhua
    Cui, Yanan
    Zhang, Pengpeng
    Liang, Xiao
    Xu, Jiali
    Liu, Xinyin
    Wu, Yuemin
    Wang, Wei
    Zhang, Fang
    Zhang, Junling
    Huang, Mengli
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Pan-Cancer Analyses Identify the CTC1-STN1-TEN1 Complex as a Protective Factor and Predictive Biomarker for Immune Checkpoint Blockade in Cancer
    Wang, Lishuai
    Ma, Tengfei
    Liu, Weijin
    Li, Heping
    Luo, Zhenhua
    Feng, Xuyang
    FRONTIERS IN GENETICS, 2022, 13
  • [6] Robust prediction of pan-cancer immune checkpoint blockade response using machine learning
    Chang, Tiangen
    Dhruba, Saugato R.
    Cao, Yingying
    Morris, Luc G.
    Ruppin, Eytan
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade
    Huang, Zhiyang
    Li, Yingying
    Zhao, Hong
    Zhao, Bin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [8] The molecular basis of the lymphocyte stability index (LSI): A pan-cancer peripheral biomarker for survival post immune checkpoint blockade (ICB)
    Watson, R.
    Tong, O.
    Little, M.
    Muldoon, D.
    Mackay, S.
    Oluwafemi, A-A.
    Sun, S.
    Milotay, G.
    Taylor, C.
    Vallance, G.
    Shine, B.
    Middleton, M. R.
    Coupe, N. A.
    Payne, M.
    Fairfax, B. P.
    ANNALS OF ONCOLOGY, 2024, 35 : S277 - S277
  • [9] Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy
    Chi Yan
    Ann Richmond
    Molecular Cancer, 20
  • [10] Pan-cancer analysis of YAP1 expression as a predictive biomarker for cancer immunotherapy
    Owonikoko, Taofeek K.
    Elliott, Andrew
    Ivanov, Andrey
    Dwivedi, Bhakti
    Walker, Phillip
    Vanderwalde, Ari M.
    Puri, Sonam
    Dacic, Sanja
    Morgensztern, Daniel
    Liu, Stephen V.
    Borghaei, Hossein
    Sica, Gabriel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345